Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$2.19B |
| 2 |
GE Vernova
GEV
|
+$1.16B |
| 3 |
Meta Platforms (Facebook)
META
|
+$501M |
| 4 |
Palantir
PLTR
|
+$451M |
| 5 |
DoorDash
DASH
|
+$411M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.22B |
| 2 |
Ascendis Pharma A/S
ASND
|
+$866M |
| 3 |
Applovin
APP
|
+$690M |
| 4 |
DAY
Dayforce
DAY
|
+$576M |
| 5 |
Workday
WDAY
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.5% |
| 2 | Healthcare | 20.49% |
| 3 | Industrials | 11.17% |
| 4 | Consumer Discretionary | 9.27% |
| 5 | Communication Services | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Aptiv
APTV
$12B
| $109M | 0.05% |
1,575,088
-23,554
| -1% | -$1.82M |
|
277
Ferrari
RACE
$63.3B
| $108M | 0.05% |
320,942
+231,614
| +259% | +$81M |
|
278
Olema Pharmaceuticals
OLMA
$1.02B
| $106M | 0.05% |
7,108,488
+398,294
| +6% | +$8.87M |
|
279
Xylem
XYL
$28.5B
| $106M | 0.05% |
883,878
-10,906
| -1% | -$1.43M |
|
280
iShares Core S&P 500 ETF
IVV
$876B
| $105M | 0.05% |
160,308
-22,226
| -12% | -$15.2M |
|
281
NRG Energy
NRG
$29.8B
| $103M | 0.05% |
703,909
+35,254
| +5% | +$5.55M |
|
|
JA
282
Janus Henderson AA-A CLO ETF
JA
$146M
| $99.9M | 0.05% |
+2,000,000
| New | +$100M |
|
283
Ventas
VTR
$48.9B
| $99.7M | 0.05% |
1,219,029
-2,506
| -0.2% | -$205K |
|
|
ABVX
284
Abivax
ABVX
$11B
| $98M | 0.05% |
878,829
+211,068
| +32% | +$25M |
|
285
Perimeter Solutions
PRM
$5.5B
| $97.9M | 0.05% |
4,007,536
+315,763
| +9% | +$8.06M |
|
286
ServiceNow
NOW
$102B
| $97.8M | 0.05% |
935,562
-1,582,499
| -63% | -$186M |
|
287
Western Alliance Bancorporation
WAL
$9.07B
| $97.2M | 0.05% |
1,372,535
-22,742
| -2% | -$1.9M |
|
288
Coca-Cola Europacific Partners
CCEP
$46.5B
| $97.1M | 0.05% |
+1,070,753
| New | +$103M |
|
289
Ciena
CIEN
$55.3B
| $96.7M | 0.05% |
249,204
-192,433
| -44% | -$58.9M |
|
290
Walmart Inc
WMT
$871B
| $96M | 0.05% |
772,518
-53,141
| -6% | -$6.52M |
|
291
TC Energy
TRP
$73.5B
| $94.6M | 0.05% |
1,516,877
-119,798
| -7% | -$7.23M |
|
292
Agree Realty
ADC
$9.68B
| $94.3M | 0.05% |
1,251,683
-994
| -0.1% | -$75.3K |
|
|
DRUG
293
Bright Minds Biosciences
DRUG
$700M
| $93.5M | 0.04% |
1,284,324
+128,329
| +11% | +$10.3M |
|
294
Euronet Worldwide
EEFT
$3.02B
| $93.4M | 0.04% |
1,406,556
+48,990
| +4% | +$3.51M |
|
295
Edwards Lifesciences
EW
$47.6B
| $93.3M | 0.04% |
1,165,604
+18,985
| +2% | +$1.57M |
|
296
Xcel Energy
XEL
$51B
| $92.4M | 0.04% |
1,163,008
-139,206
| -11% | -$10.9M |
|
297
Credo Technology Group
CRDO
$39.7B
| $92.3M | 0.04% |
983,814
-607,534
| -38% | -$73.9M |
|
|
GRMN
298
Garmin
GRMN
$46.9B
| $92.3M | 0.04% |
397,876
-45,720
| -10% | -$10.2M |
|
299
Baker Hughes
BKR
$56.8B
| $90.9M | 0.04% |
1,488,408
-215,489
| -13% | -$12.5M |
|
300
Pfizer
PFE
$140B
| $90.5M | 0.04% |
3,223,714
-5,562,370
| -63% | -$148M |
|
Similar funds
Janus Henderson Group's Q1 2026 Portfolio in Review
As of Q1 2026, Janus Henderson Group held 2,488 positions worth $209B, down 6.2% from $223B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Janus Henderson Group's Q1 2026 filing shows 82 new, 739 increased, 627 reduced and 81 closed positions. Its largest new stake was Forgent Power Solutions: 7,769,612 shares worth $227M. The largest sale was Microsoft, an estimated $1.22B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2026 buy was Forgent Power Solutions: 7,769,612 shares worth $227M.
- Janus Henderson Group added most to AstraZeneca in Q1 2026, an estimated $2.19B increase.
- Janus Henderson Group's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.22B.
- Janus Henderson Group fully exited Ascendis Pharma A/S in Q1 2026, selling an estimated $866M.
- Janus Henderson Group's ten largest holdings make up 30% of its $209B portfolio in Q1 2026.
- Janus Henderson Group opened 82 new positions and closed 81 in Q1 2026.
- Janus Henderson Group's portfolio value fell 6.2% quarter-over-quarter to $209B.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.